VN

Vijay Nahar

Active Director Director DIN 00310287
DIN 00310287 First appointment Sep 2007 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 6 historical roles
Total affiliations 8 Since Sep 2007
Shareholding value •••• Premium profile

About Vijay Nahar

Data last updated:

Vijay Nahar is a Director at Trigenesis Lifesciences Private Limited (since 2019) and Director at Trigenesis Biosciences Private Limited (since 2011). The companies operate in Pharma and Trading. The 2 current companies with reported revenue have a combined latest revenue of ₹1.57 Cr; the largest is Trigenesis Lifesciences Private Limited at ₹1.44 Cr (FY 2025). Earlier, Vijay Nahar was a Director at Lifelong Biological Private Limited (2019–2022) and Director at Plasmagen Biosciences Private Limited (2015–2017) and 4 more.

DIN 00310287
Primary Designation Director
Industry Pharma
First Appointment 17 Sep 2007
Oldest Company Age 22 yrs
Largest company Trigenesis Lifesciences Private Limited · ₹1.44 Cr (FY 2025)
Combined revenue ₹1.57 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director15 Jul 20192004₹1.44 Cr (FY 2025)Active
Director19 Jan 20112011₹12.6 Lakh (FY 2022)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Lifelong Biological Private Limited U24239KA2007PTC043662
Director16 Dec 20192007₹82,791 (FY 2025)Active
Director31 Mar 20152010₹162 Cr (FY 2025)Active
Avinya Lifesciences Private Limited U74999KA2018PTC110215
Director17 Feb 20182018₹1.2 Lakh (FY 2025)Active
R S M Pharma Private Limited U85110KA1989PTC009974
Managing Director17 Sep 20071989₹363 Cr (FY 2025)Active
Director24 Sep 20122012₹68.86 Cr (FY 2017)Active
Splendina Healthcare Private Limited U51397KA2010PTC055190
Director17 Jun 20112010₹13 Lakh (FY 2022)Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Vijay Nahar

Directorship timeline

Open interactive timeline →
Trigenesis Lifesciences Private Limited
Splendina Healthcare Private Limited
Trigenesis Biosciences Private Limited
Lifelong Biological Private Limited
Premium access

Shareholding and investment profile for Vijay Nahar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vijay Nahar

Vijay Nahar currently holds 2 directorships: Trigenesis Lifesciences Private Limited (Director, since 15 Jul 2019, revenue ₹1.44 Cr (FY 2025)); Trigenesis Biosciences Private Limited (Director, since 19 Jan 2011, revenue ₹12.6 Lakh (FY 2022)).

Vijay Nahar was first appointed on 17 Sep 2007 as Managing Director at R S M Pharma Private Limited. The most recent appointment on record is 16 Dec 2019 at Lifelong Biological Private Limited.

The 2 current companies of Vijay Nahar that report revenue have a combined latest revenue of ₹1.57 Cr: Trigenesis Lifesciences Private Limited ₹1.44 Cr (FY 2025); Trigenesis Biosciences Private Limited ₹12.6 Lakh (FY 2022).

Vijay Nahar held 6 earlier board appointments: Lifelong Biological Private Limited (Director, 16 Dec 2019 to 29 Dec 2022); Plasmagen Biosciences Private Limited (Director, 31 Mar 2015 to 01 Jul 2017); Avinya Lifesciences Private Limited (Director, 17 Feb 2018 to 01 Apr 2021); R S M Pharma Private Limited (Managing Director, 17 Sep 2007 to 15 Jun 2019); Hospitalis Supply Solutions Private Limited (Director, 24 Sep 2012 to 14 Jan 2014); and 1 more.

The current boards of Vijay Nahar's companies include Bhawarlal (Trigenesis Lifesciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available